The molecular zip code research suggests that a kinase inhibitor could be a major treatment for Huntington's Disease.
Lowered BDNF levels in HD patients can be measured through blood tests and could serve as a biomarker.
HD specific human cell systems to be developed to improve drug discovery.
Researchers report solid progress since the 2006 HDSA convention.
Researchers report solid progress since last year.
Mac Casale, Ph.D. reviews a poster presentation on a research study involving BDNF.
Researchers generated a mouse which progressively lost Dopamine 1 receptor cells and got Huntington's Disease like symptoms.
Researchers have discovered that excess copper plays a role in Huntington's Disease pathology.
The University of Iowa is asking for young adults to participate in a research study about growing up as a teenager in an HD family.
Significant research is taking place in all the disciplines that lead from basic research to an approved treatment.